Header Logo

Connection

JOHN MANNING to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications JOHN MANNING has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
JOHN MANNING
Connection Strength
0.082
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase. J Clin Oncol. 2011 Jun 10; 29(17):e514-6.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.